Chronic lymphocytic leukemia-- or CLL-- is a type of cancer that happens in your blood and bone marrow, the spongy tissue inside your bones. While the exact cause isn't known, doctors do know that ...

and chronic myeloid leukemia (CML), has decreased, while the incidence of others, including chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML), have increased in most countries ...

Over the past few years, more effective therapies have emerged in the treatment of chronic lymphocytic leukemia (CLL); these are mainly combinations of immunotherapy with fludarabine-based regimens.

Lisaftoclax is under clinical development by Ascentage Pharma Group International and currently in Phase II for Myelodysplastic Syndrome.

Lisaftoclax is under clinical development by Ascentage Pharma Group International and currently in Phase II for Primary Systemic Amyloidosis.